Trademark: 88260489
Status Date
Monday, April 12, 2021
Filing Date
Monday, January 14, 2019
Published for Opposition
Tuesday, July 14, 2020
Abandoned Date
Monday, April 12, 2021
5 Pharmaceutical preparations for hematopoietic growth factors; pharmaceutical preparations, namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell production
Apr 12, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 12, 2021
Abandonment - No Use Statement Filed
Sep 8, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 14, 2020
Published For Opposition
Jun 24, 2020
Notification Of Notice Of Publication E-Mailed
Jun 11, 2020
Law Office Publication Review Completed
Jun 2, 2020
Assigned To Lie
May 26, 2020
Assigned To Lie
May 19, 2020
Approved For Pub - Principal Register
May 19, 2020
Previous Allowance Count Withdrawn
Apr 15, 2020
Automatic Update Of Assignment Of Ownership
Mar 18, 2020
Automatic Update Of Assignment Of Ownership
Oct 16, 2019
Automatic Update Of Assignment Of Ownership
May 14, 2019
Attorney Review/Decision On Amendment Required
May 14, 2019
Withdrawn From Issue - Incoming Corr Received
May 14, 2019
Assigned To Petition Staff
May 14, 2019
Assigned To Petition Staff
May 7, 2019
Official Gazette Publication Confirmation E-Mailed
May 7, 2019
Published For Opposition
Apr 17, 2019
Notification Of Notice Of Publication E-Mailed
Apr 9, 2019
Teas Post Publication Amendment Received
Mar 27, 2019
Approved For Pub - Principal Register
Mar 27, 2019
Assigned To Examiner
Feb 5, 2019
New Application Office Supplied Data Entered In Tram
Jan 17, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
